How Much HCG Should You Take With TRT?

Most men on testosterone replacement therapy who add HCG use between 250 and 500 IU per injection, given two or three times per week, for a weekly total somewhere in the 500 to 1,500 IU range. That spread exists because the goal of HCG varies from person to person. Some men want to keep their testicles from shrinking. Others are trying to preserve fertility. A few are chasing a specific intratesticular testosterone level. The “right” dose depends on which of those outcomes matters most, and the clinical evidence points to slightly different numbers for each.

Why HCG Gets Added to TRT in the First Place

When you inject exogenous testosterone, your brain detects the rising blood levels and dials back its own signaling to the testes. The pituitary stops releasing luteinizing hormone (LH), and without LH, Leydig cells in the testicles produce far less testosterone locally. Intratesticular testosterone can plummet to a fraction of its normal concentration, and sperm production suffers as a direct consequence.¹ The testicles also physically shrink over time without that internal stimulation.

HCG mimics LH. It binds to the same receptor on Leydig cells and tells them to keep producing testosterone locally, even though the pituitary has gone quiet. In laboratory settings, HCG is roughly ten times more potent than LH at triggering the initial signaling cascade inside those cells, though the end result in terms of testosterone output is comparable at equivalent doses.² That potency is part of why relatively small doses of HCG can do meaningful work alongside TRT.

What the Dose-Response Research Actually Shows

The most cited dose-finding studies come from a research group that suppressed men’s natural gonadotropins with exogenous testosterone and a GnRH antagonist, then added back various doses of HCG to see what happened inside the testes. In one study, men receiving just 250 IU of HCG every other day maintained intratesticular testosterone at about 7% below their pre-treatment baseline. Bump the dose to 500 IU every other day, and intratesticular testosterone actually exceeded baseline by roughly 26%. Even 125 IU every other day kept levels from bottoming out completely, though it did allow a 25% drop from baseline.³

A follow-up study from the same group confirmed the dose-dependent relationship, showing that intratesticular testosterone climbed in a clear staircase pattern from near-zero (in men given no HCG at all) up through progressively higher concentrations as the HCG dose increased. At 125 IU daily, intratesticular testosterone rose dramatically compared to placebo, and serum testosterone tracked upward as well.⁴

These studies are the backbone of clinical dosing decisions. They tell us that you do not need large doses to maintain meaningful testicular function. They also tell us that more HCG does predictably produce more intratesticular testosterone, which matters for men whose primary concern is fertility rather than just preventing atrophy.

Common Dosing Protocols in Practice

Clinics and prescribing physicians generally land on one of a few standard approaches, all loosely rooted in the research above:

250 IU three times per week: A conservative starting point, totaling 750 IU weekly. This is often enough to prevent noticeable testicular shrinkage and maintain some baseline intratesticular testosterone. It is the go-to for men who are not actively trying to conceive.
500 IU two to three times per week: Yields 1,000 to 1,500 IU weekly. More common when fertility preservation is a priority, or when a man has already noticed significant atrophy on TRT alone. This range more closely approximates the doses that kept intratesticular testosterone at or above baseline in the research studies.
1,000 IU two to three times per week: Occasionally used in fertility recovery protocols, often alongside FSH, when a man is actively trying to restart sperm production after a period of TRT. This sits at the upper edge of what most clinicians are comfortable prescribing long-term because of desensitization concerns.

There is no universally agreed-upon “standard dose.” Guidelines from major endocrine societies acknowledge HCG as a tool for fertility preservation during TRT but stop short of specifying an exact protocol, which means prescribing varies widely between providers. If your doctor starts you at 500 IU twice a week and another clinic starts someone at 250 IU three times a week, both are within the range supported by the available evidence.

How Often to Inject and Why It Matters

HCG has a half-life of about 2.3 days after injection, meaning half the drug has cleared your body roughly 55 hours later.⁵ That half-life explains why every-other-day or three-times-per-week dosing is the most common schedule. Injecting once a week would leave a long trough during which the Leydig cells receive minimal stimulation. Twice a week is a reasonable minimum for keeping levels more or less steady, and three times a week smooths things out further.

Some men inject daily at lower per-dose amounts, particularly if they are already doing daily testosterone injections and want to combine the two in the same routine. The pharmacodynamics support this approach: smaller, more frequent doses keep serum HCG within a tighter range and avoid the peaks that come with larger, less frequent injections. Whether that tighter range translates to meaningfully better outcomes is not established in controlled studies, but it is a logical extrapolation from the half-life data.

Subcutaneous or Intramuscular

HCG can be injected either subcutaneously (into fat, usually in the abdomen) or intramuscularly (into muscle, often the thigh or deltoid). A head-to-head comparison found that subcutaneous injection delays the peak concentration somewhat and extends the time the drug stays in circulation, but the hormonal response, including testosterone production, was identical between the two routes.⁶ Most men on TRT prefer subcutaneous injection because it uses a smaller needle, hurts less, and can be done with the same insulin syringes they may already use for testosterone. The slightly slower absorption is arguably a minor benefit, since it produces a more gradual rise and a longer tail rather than a sharp spike.

When Higher Doses Backfire

More HCG is not always better. Leydig cells can become less responsive to gonadotropin stimulation when exposed to very high doses for extended periods. This phenomenon, sometimes called Leydig cell desensitization, has been documented in adult testicular tissue and stands in contrast to fetal Leydig cells, which appear able to tolerate prolonged high-dose stimulation without losing sensitivity.⁷ In practical terms, this means that chronically dosing HCG at, say, 2,000 to 5,000 IU several times a week could eventually blunt the very response you are trying to maintain.

The threshold where desensitization becomes clinically relevant in men on TRT is not precisely defined, but most specialists keep ongoing adjunctive doses below 1,500 IU per injection to stay well within a safe margin. Short-term “burst” protocols at higher doses are sometimes used when restarting fertility, but those tend to be supervised more closely and limited in duration.

There is also a more mundane risk to overdoing it. HCG raises estradiol, because the intratesticular testosterone it produces gets converted by aromatase just like any other testosterone. Men who run high doses of HCG alongside TRT sometimes find they need an aromatase inhibitor to manage estrogen-related side effects like water retention or breast tenderness. Keeping HCG in the lower-to-moderate range reduces the odds of that cascade.

Fertility Preservation and Recovery

For men who want children in the future, HCG is the primary pharmacological tool for keeping sperm production alive during TRT. The principle is straightforward: by maintaining intratesticular testosterone at levels high enough to support spermatogenesis, HCG can prevent the near-total shutdown of sperm output that exogenous testosterone alone would cause.⁸

When sperm production has already been suppressed, the recovery data is encouraging but not instantaneous. In a cohort of men who had been on testosterone therapy and were then treated with HCG (often combined with FSH), about three-quarters showed improved semen parameters over an average treatment period of seven months. Among men who started with no detectable sperm at all, roughly 65% regained at least some measurable sperm count. Those who started with very low counts had even better recovery rates.⁹ These numbers argue for using HCG proactively during TRT if future fertility is a consideration, rather than waiting until you want to conceive and then trying to reverse the damage.

The doses used in fertility recovery protocols tend to be on the higher end of the spectrum, often 1,500 to 3,000 IU two to three times per week, sometimes with FSH added. These are temporary, goal-directed protocols rather than indefinite maintenance doses. Once semen parameters recover sufficiently, the HCG dose can be adjusted back to a lower maintenance level or discontinued depending on the plan.

HCG as a Standalone Alternative

Some men with mildly low testosterone use HCG on its own rather than adding exogenous testosterone. When used as monotherapy in men with total testosterone above 300 ng/dL but symptomatic hypogonadism, HCG raised average testosterone by about 50%, from roughly 360 ng/dL to about 520 ng/dL over a median treatment period of eight months. Half of those patients reported subjective symptom improvement.¹⁰

Those gains are modest compared to what TRT itself delivers, which is why HCG monotherapy has not replaced testosterone as the standard treatment for hypogonadism. But for younger men who want to treat symptoms without suppressing their own gonadotropin axis, or for men who prioritize fertility above all else, monotherapy remains a viable middle ground. The doses used in monotherapy studies tend to be higher than adjunctive doses, often in the range of 1,500 to 3,000 IU two to three times per week, because the HCG has to do all the work rather than supplementing exogenous testosterone.

Access and Cost Have Changed Significantly

If you tried to get HCG from a compounding pharmacy before 2020 and then tried again afterward, you likely noticed a dramatic difference. In March 2020, HCG was reclassified as a biologic under U.S. law, which meant compounding pharmacies could no longer produce it unless they obtained a Biologics License Application. The regulatory and financial burden of that license, including annual fees and reinspection costs that run into tens of thousands of dollars, effectively pushed most compounding pharmacies out of the HCG market.¹¹

The practical fallout for patients has been real. Previously inexpensive compounded HCG became harder to find, and men were pushed toward brand-name pharmaceutical products at significantly higher prices. Global supply chain disruptions compounded the problem further.¹² Some clinics have responded by switching patients to alternative gonadotropin preparations or adjusting dosing to stretch supplies. Others have explored enclomiphene or low-dose clomiphene citrate as partial substitutes, though these work by a different mechanism (stimulating the pituitary rather than directly stimulating Leydig cells) and are not pharmacologically equivalent.

This access issue is worth understanding because it sometimes drives dosing decisions. A man who would ideally use 500 IU three times a week might settle for 250 IU twice a week simply because the cost of pharmaceutical-grade HCG makes the higher protocol unaffordable. If you find your prescribed dose feels lower than what you have read about online, the explanation may be economic rather than medical.

Monitoring While on HCG and TRT

Adding HCG to TRT does not eliminate the need for regular bloodwork, and it introduces a few additional things worth tracking. Estradiol is the big one. Because HCG boosts intratesticular testosterone production on top of whatever exogenous testosterone you are injecting, total estrogen conversion increases. If you start experiencing symptoms that suggest elevated estradiol, your provider can check levels and adjust either the HCG dose or add a low-dose aromatase inhibitor.

Standard TRT monitoring still applies as well. Cardiovascular risks from testosterone therapy include elevated blood pressure and rising red blood cell counts, and periodic checks of hematocrit are important. If hematocrit climbs above about 52%, therapeutic blood donation or a dose adjustment is typically warranted.¹³ HCG itself does not directly raise hematocrit in the way exogenous testosterone does, but by adding to total androgen exposure, it can contribute indirectly.

Semen analysis is the other monitoring tool that matters if fertility is your reason for using HCG. Bloodwork alone cannot tell you whether spermatogenesis is being maintained. A baseline semen analysis before starting TRT, followed by periodic checks every six to twelve months, gives you actual data rather than assumptions. Many men on TRT plus HCG assume they remain fertile because they are “taking something for it,” but the only way to know is to check.

Testicular Size and the Cosmetic Angle

A significant number of men add HCG to their TRT protocol not for fertility but simply to prevent their testicles from shrinking. Testicular atrophy on TRT is common and can be noticeable within a few months. It is not medically dangerous, but it bothers many men for cosmetic or psychological reasons. Even low-dose HCG, in the 250 IU range a few times a week, provides enough Leydig cell stimulation to maintain at least partial testicular volume. Whether it fully prevents atrophy depends on the individual and the TRT dose, but most men report that HCG meaningfully slows or stops the shrinkage they would otherwise experience.

This is one of the areas where the dose decision is more subjective. If fertility is irrelevant and your only goal is maintaining testicular size, the lower end of the dosing range is often sufficient. If you are trying to preserve sperm production at the same time, you likely need a higher dose. Discussing your specific goals with your prescribing physician is more productive than chasing a single number from the internet, because the “right” dose genuinely differs based on what you are trying to accomplish.